Journal of Medicinal Chemistry · 2001 · 59 citations · 9 references
MedicineMedicinal ChemistryPharmacologyCancer PharmacologyMolecular OncologyMolecular PharmacologyCytotoxic ChemotherapyDna ChemistryOncology PharmacologyChemical Structure-activity RelationshipsCytotoxicity AssaysElectron-withdrawing GroupsFluorometric Dna MeasurementMedicinal HeterocyclesPyrimidine Analogues
A series of DNA-binding potential antitumor agents bearing a cationic carboxamide side chain attached in position peri to an electron-withdrawing atom, N-5,2-di(omega-aminoalkyl)-2,6-dihydropyrazolo[3,4,5-kl]acridine-5-carboxamides, has been prepared by reaction of the appropriate 1-chloro-9-oxo-9,10-dihydro-4-acridinecarboxamides with the suitable (omega-aminoalkyl)hydrazine. The noncovalent DNA-binding properties of these compounds have been examined using a fluorometric technique. In vitro cytotoxic potency of these derivatives toward the human colon adenocarcinoma cell line (HT29) is described and compared to that of reference drugs. Structure-activity relationships are discussed. Two highly DNA-affinic and potent cytotoxic compounds, 4m,o, have been identified as new leads in the antitumor strategies.
9
Leslie W. Deady, Anthony J. Kaye, Graeme J. Finlay et al. · Journal of Medicinal Chemistry · 1997 · 122 citations
A. Paul Krapcho, M. E. PETRY, Zelleka Getahun et al. · Journal of Medicinal Chemistry · 1994 · 104 citations
Ippolito Antonini, Paolo Polucci, Lloyd R. Kèlland et al. · Journal of Medicinal Chemistry · 1999 · 68 citations